P16.05 Real World Data of First-Line Treatment With Pembrolizumab for Highly PD-L1-Expressing NSCLC

Autor:	Kobayashi, M. 1, Mizugaki, H. 2, Ikezawa, Y. 3, Morita, R. 4, Tateishi, K. 5, Yokoo, K. 6, Sumi, T. 7, Kikuchi, H. 8, Nagano, Y. 9, Nakamura, A. 10, Aso, M. 11, Kimura, N. 12, Yoshiike, F. 13, Furuta, M. 14, Tanaka, H. 15, Sekikawa, M. 16, Hachiya, T. 17, Fujita, Y. 18, Oizumi, S. 19
Zdroj:	In Journal of Thoracic Oncology October 2021 16(10) Supplement:S1017-S1017
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu